Titan Pharmaceuticals, Inc. Share Price Nasdaq
Equities
US8883143096
Pharmaceuticals
Sales 2022 | 6L 4.66Cr | Sales 2023 | 2L 1.54Cr | Capitalization | 62.15L 52Cr |
---|---|---|---|---|---|
Net income 2022 | -1Cr -84Cr | Net income 2023 | -50L -42Cr | EV / Sales 2022 | 15.6 x |
Net cash position 2022 | 27.5L 23Cr | Net cash position 2023 | 61.95L 52Cr | EV / Sales 2023 | 0.11 x |
P/E ratio 2022 |
-1.03
x | P/E ratio 2023 |
-1.11
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 54.53% |
Members of the board | Title | Age | Since |
---|---|---|---|
Avraham Ben-Tzvi
BRD | Director/Board Member | 53 | 15/22/15 |
Gim Shen Seow
CEO | Chief Executive Officer | 42 | 12/23/12 |
Brynner Chiam
BRD | Director/Board Member | - | 12/23/12 |
1st Jan change | Capi. | |
---|---|---|
+48.53% | 78TCr | |
+40.67% | 63TCr | |
-6.37% | 35TCr | |
+20.93% | 33TCr | |
+8.21% | 30TCr | |
+16.75% | 25TCr | |
-1.19% | 22TCr | |
+10.85% | 21TCr | |
+4.40% | 16TCr |